Page last updated: 2024-11-03

ro 31-8220 and DDPAC

ro 31-8220 has been researched along with DDPAC in 1 studies

Ro 31-8220: a protein kinase C inhibitor

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shim, KH1
Kim, SH1
Hur, J1
Kim, DH1
Demirev, AV1
Yoon, SY1

Other Studies

1 other study available for ro 31-8220 and DDPAC

ArticleYear
Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster.
    Neurobiology of disease, 2019, Volume: 130

    Topics: Animals; Disease Models, Animal; Drosophila melanogaster; Drug Evaluation, Preclinical; Frontotempor

2019